Press release MHRA approves GLP –1 receptor agonist semaglutide to reduce possibility of great heart troubles in obese or overweight Grown ups Semaglutide is the very first fat loss drug permitted in the UK being a preventative treatment for those with set up heart problemsIn reports with rodents, Wegovy® and medicines that do the job like Wegov